Ciazil drug whose main ingredient is Epirubicin hydrochloride is widely used in the treatment of neoplastic diseases such as: malignant lymphoma, breast cancer, soft tissue sarcoma, liver cancer, stomach, pancreas, sigmoid rectum, lung cancer , hill and neck cancer, ovarian cancer, and leukemia. The drug is given as an intravenous injection or a drop into the bladder.